Numinus Wellness Inc.

corporate_fare Company Profile

Numinus Wellness Inc.

NUMIF·OTC·Life Sciences

Numinus Wellness Inc. provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States. The company operates through two segments: Clinical Research Operations and Practitioner Training. It also offers clinical research management services to academic institutions and biotechnology companies. Additionally, Numinus Wellness Inc. provides education and training for research and drug development organizations to support clinical trials and commercialization efforts. The company is headquartered in Vancouver, Canada.

Numinus Wellness Inc. (OTC:NUMIF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for NUMIF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-28, rated 7/10.

Recent high-impact activity:

Numinus Q4 Revenue Jumps 29% to $2.3M, Gross Margin Hits 61% (2026-08-28)

show_chartPrice Chart

Loading chart...

feed NUMIF - Latest Insights

Filing Type

Date Range

NUMIF

Aug 28, 2026, 5:00 PM EDT

Source: TMX Newsfile

Importance Score:

Numinus Q4 Revenue Jumps 29% to $2.3M, Gross Margin Hits 61%

Price at Filing: $0.0389

Real-time Price: $0.021

Change: -$0.0179 (-46%)

Market Cap: $6.732M

Sentiment: Positive

View Wiseek Article

Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets

corporate_fare Company Profile